Fig. 2From: MesenchymAl stromal cells for Traumatic bRain Injury (MATRIx): a study protocol for a multicenter, double-blind, randomised, placebo-controlled phase II trialTimepoints for longitudinal assessment of secondary outcomes. SD  study drugBack to article page